These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1702145)

  • 1. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
    Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
    J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ; Kantarjian H; Talpaz M; Redman J; Koller C; Barlogie B; Velasquez W; Plunkett W; Freireich EJ; McCredie KB
    Blood; 1989 Jul; 74(1):19-25. PubMed ID: 2473795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
    Pillay GS; Wood L; Jacobs P
    S Afr Med J; 1996 Aug; 86(8):949-51. PubMed ID: 8823419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
    Leporrier M; Chevret S; Cazin B; Boudjerra N; Feugier P; Desablens B; Rapp MJ; Jaubert J; Autrand C; Divine M; Dreyfus B; Maloum K; Travade P; Dighiero G; Binet JL; Chastang C;
    Blood; 2001 Oct; 98(8):2319-25. PubMed ID: 11588025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
    Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
    J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
    Angelopoulou MA; Poziopoulos C; Boussiotis VA; Kontopidou F; Pangalis GA
    Leuk Lymphoma; 1996 Apr; 21(3-4):321-4. PubMed ID: 8726414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA; Mittelman A; Lichtman SM; Silver RT; Budman DR; Ahmed T; Feldman EJ; Coleman M; Arnold PM; Arlin ZA
    J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
    J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
    Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.
    Robertson LE; O'Brien S; Kantarjian H; Koller C; Beran M; Andreeff M; Lerner S; Plunkett W; Keating MJ
    Leukemia; 1995 Sep; 9(9):1444-9. PubMed ID: 7658710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
    Keating MJ; O'Brien S; Lerner S; Koller C; Beran M; Robertson LE; Freireich EJ; Estey E; Kantarjian H
    Blood; 1998 Aug; 92(4):1165-71. PubMed ID: 9694704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
    O'Brien S; Kantarjian H; Beran M; Smith T; Koller C; Estey E; Robertson LE; Lerner S; Keating M
    Blood; 1993 Sep; 82(6):1695-700. PubMed ID: 8400226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia.
    Robertson LE; O'Brien S; Kantarjian H; Koller C; Beran M; Andreeff M; Lerner S; Keating MJ
    Leukemia; 1995 Jun; 9(6):943-5. PubMed ID: 7596181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.